Clinical trial · Observational
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Cancer (Primary and Metastatic) | Malignant Liver Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| liver resection | Procedure | — | UNRESOLVED |
| Systemic therapy combined with locoregional interventions | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Liver resection group
- interventionNames
- Procedure: liver resection
- label
- Non-surgery group
- interventionNames
- Drug: Systemic therapy combined with locoregional interventions
Primary outcomes (1)
- measure
- overall survival
- timeFrame
- From date of treatment until the date of death from any cause, assessed up to 100 months
Secondary outcomes (1)
- measure
- Incidence of Adverse Events
- timeFrame
- Within 30 days following interventions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female aged ≥18 years at the time of signing the informed consent form * Clinically or histologically confirmed diagnosis of liver cancer * Recieving treatment and follow-up in Tongji Hospital Exclusion Criteria: \- Refuse participanting in this study
References
Publications (0)
Data not yet available